In 2006, OOO NPP PHARMACLON® received a license (№ 99-04-000133 from 19.01.2006) on the production and implementation of the first and only currently in Russia, is patented and officially registered domestic medicinal product on the basis of gamma-interferon "INGARON®" (interferon-gamma human recombinant) in two dosage forms - in the form of a lyophilisate for preparation of solution for intramuscular and subcutaneous administration and in the form of a lyophilisate for preparation of solution for intranasal administration.